Which Publicly Traded Companies Are Leading the GLP-1 Drug Race for Diabetes and Obesity?
GLP-1 drugs have become one of the biggest growth engines in pharmaceuticals, moving from a diabetes-focused treatment category into a […]
GLP-1 drugs have become one of the biggest growth engines in pharmaceuticals, moving from a diabetes-focused treatment category into a […]
Oncology has remained one of the most important investment areas in healthcare, attracting venture capital firms, corporate investors and pharmaceutical
For a biotech or pharmaceutical company preparing a first-in-human (FIH) study with an oral solid dosage (OSD), the CDMO needs
Applied Behavior Analysis (ABA) practices increasingly depend on specialized software to manage clinical documentation, scheduling, data collection, billing, authorizations, payroll
MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany, provides laboratory products, chemicals, technologies and services used across
GLP-1 medicines have moved from a specialist diabetes treatment into mainstream weight-management conversations. Adoption is now being influenced by clinical
For rheumatologists treating psoriatic arthritis (PsA), choosing a therapy is not only about efficacy and safety. Formulary position, prior authorization,
For parents, healthcare professionals and retailers in the UK, innovation in infant feeding is moving beyond basic nutrition. Brands are
For U.S. medical equipment suppliers, Philips Respironics is a particularly important company to evaluate from a safety, fulfillment and replacement-service
For an investor or financial analyst, “patient success” in contact lenses should be evaluated beyond marketing testimonials. Useful indicators include